Friends Research Institute, Inc.
Clinical trials sponsored by Friends Research Institute, Inc., explained in plain language.
-
Jail telemedicine study aims to keep opioid treatment on track after release
Disease control OngoingThis study tests whether giving a long-acting buprenorphine shot (BRIXADI) via telemedicine to 30 people in jail, just before they are released, helps them stay on treatment and avoid opioid use. Participants switch from daily sublingual buprenorphine to weekly and then monthly i…
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Bridge drug may help parolees beat opioid addiction
Disease control TerminatedThis study tests whether giving buprenorphine (a medication for opioid addiction) as a bridge treatment helps people on probation or parole stop using illicit opioids and stay in treatment. About 320 adults in Baltimore will either receive the bridge treatment or be referred to a…
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Jail-to-Community study tests monthly shots to fight opioid relapse
Disease control OngoingThis study compares two long-acting injectable medications—extended-release naltrexone and extended-release buprenorphine—for people with opioid use disorder who are leaving jail. About 240 participants from Maryland jails will receive one of the two medications monthly for six m…
Phase: PHASE2, PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 12, 2026 13:41 UTC